Thus, NAMPT and CtBP inhibitors exert highly cooperative cancer-selective antiproliferative effects in certain PDAC cell lines, but not in untransformed pancreatic ductal cells or PDAC cells where alternative NAD synthesis pathways may be active. Here, CTBP1 is linked to cancer.